Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article Report
  • Published:

Tranexamic acid and uremic bleeding: evidence-based treatment recommendations

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mezzano D et al. (1996) Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 76: 312–321

    Article  CAS  Google Scholar 

  2. Mezzano D et al. (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60: 1844–1850

    Article  CAS  Google Scholar 

  3. Mezzano D et al. (1999) Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 82: 1250–1254

    Article  CAS  Google Scholar 

  4. Mezzano D et al. (2000) Fast decrease of bleeding time by tranexamic acid in uremia. Thromb Haemost 83: 785

    Article  CAS  Google Scholar 

  5. Vujkovac B et al. (1998) Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 31: 536–538

    Article  CAS  Google Scholar 

  6. Vujkovac B and Sabovic M (2000) Treatment of subdural and intracerebral haematoma in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant 15: 107–109

    Article  CAS  Google Scholar 

  7. Sabovic M et al. (2003) Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 18: 1388–1391

    Article  CAS  Google Scholar 

  8. Sabovic M et al. (2005) The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. Thromb Haemost 94: 1245–1250

    Article  CAS  Google Scholar 

  9. Vujkovac B and Sabovic M (2006) A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid. Blood Coagul Fibrinolysis 17: 589–591

    Article  Google Scholar 

  10. Mannucci PM et al. (1983) Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12

    Article  CAS  Google Scholar 

  11. Alarcón F et al. (1985) Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time of uremic patients. Rev Med Chile 113: 763–768

    PubMed  Google Scholar 

  12. Rodgers RP and Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16: 1–20

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diego Mezzano.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Downey, P., Tagle, R., Pereira, J. et al. Tranexamic acid and uremic bleeding: evidence-based treatment recommendations. Nat Rev Nephrol 3, E2 (2007). https://doi.org/10.1038/ncpneph0528

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpneph0528

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing